with 100% Solved | Graded A+
Biometrics - ✔✔A method of verifying an individual's identity based on
measurement of the individual's physical features or repeatable actions where
those features and or actions are both unique to that individual and
measurable. (21 CFR, Sec. 11.3)
Closed System - ✔✔An environment in which system access is controlled by
persons who are responsible for the content of electronic records that are on
the system. (21 CFR, Sec. 11.3)
Digital Signature - ✔✔An electronic signature based upon cryptographic
methods of originator authentication, computed by using a set of rules and a set
of parameters such that the identity of the signer and the integrity of the data
can be verified. (21 CFR, Sec. 11.3)
Electronic Record - ✔✔Any combination of text, graphics, data, audio, pictorial,
or other information representation in digital form that is created, modified,
maintained, archived, retrieved or distributed by a computer system. (21 CFR,
Sec. 11.3)
1|Page
©KERRYMARTIN 2025/2026. YEAR PUBLISHED 2025.
,Electronic Signature - ✔✔A computer data compilation of any symbol or series
of symbols executed, adopted, or authorized by an individual to be legally
binding equivalent of the handwritten signature. (21 CFR, Sec. 11.3)
Open system - ✔✔An environment in which system access is not controlled by
persons who are responsible for the content of the electronic records that are
on the system. (21 CFR, Sec. 11.3)
Clinical Investigation - ✔✔Any experiment that involves a test article and one or
more human subjects and that either is subject to requirements for prior
submission to the Food and Drug Administration under section 505(i) or 520(g)
of the act, or is not subject to requirements for prior submission to the Food and
Drug Administration under these sections of the Act, but the results of which
are intended to be submitted later to, or held for inspection by, the Food and
Drug Administration as part of an application for a research or marketing
permit. (21 CFR, sec. 50.3)
Investigator - ✔✔An individual who actually conducts a clinical investigation,
i.e., under whose immediate direction the test article is administered or
dispensed to, or used involving, a subject, or, in the event of an investigation
conducted by a team of individuals, is the responsible leader of that team. (21
CFR, sec. 50.3)
2|Page
©KERRYMARTIN 2025/2026. YEAR PUBLISHED 2025.
, Sponsor - ✔✔A person who initiates a clinical investigation but who does not
actually conduct the investigation, i.e., the test article is administered or
dispensed to, or used involving, a subject under the immediate direction of
another individual. A person other than the individual (e.g., corporation or
agency) that uses one or more of its own employees to conduct a clinical
investigation it has initiated it has initiated is considered to be a sponsor (not a
sponsor-investigator), and the employees are considered to be investigators.
(21 CFR, sec. 50.3)
Sponsor-Investigator - ✔✔An individual who both initiates and actually
conducts, alone or with others, a clinical investigation, i.e., under whose
immediate direction the test article is administered or dispensed to, or used
involving, a subject. The term does not include any other person other than an
individual, e.g. corporation or agency. (21 CFR, sec. 50.3)
Handwritten Signature - ✔✔The scripted name or legal mark of an individual
handwritten by that individual. (21 CFR, Sec. 11.3)
Act - ✔✔The Food, Drug and Cosmetic Act, as amended.
3|Page
©KERRYMARTIN 2025/2026. YEAR PUBLISHED 2025.